Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study

Background: Angiotensin Converting Enzyme inhibitors (ACEis) and beta-blockers (BB) are suggested to prevent and treat trastuzumab-related cardiac toxicity. We performed a prospective clinical trial in women experiencing mild cardiac toxicity (MCT) while on adjuvant treatment with trastuzumab. Metho...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancers (Basel)
Autori principali: Geuna, Elena, Lombardi, Pasquale, Martinello, Rossella, Garino, Davide, Bonzano, Alessandro, Galizia, Danilo, Nuzzo, Annamaria, Berchialla, Paola, Becco, Paolo, Mangioni, Monica, De Zarlo, Lorena, Montemurro, Filippo
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072182/
https://ncbi.nlm.nih.gov/pubmed/32023877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020327
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi